2008
DOI: 10.1021/ci700398h
|View full text |Cite
|
Sign up to set email alerts
|

Docking Ligands into Flexible and Solvated Macromolecules. 2. Development and Application of Fitted 1.5 to the Virtual Screening of Potential HCV Polymerase Inhibitors

Abstract: HCV NS5B polymerase is a validated target for the treatment of hepatitis C, known to be one of the most challenging enzymes for docking programs. In order to improve the low accuracy of existing docking methods observed with this challenging enzyme, we have significantly modified and updated F itted 1.0, a recently reported docking program, into F itted 1.5. This enhanced version is now applicable to the virtual screening of compound libraries and includes new features such as filters and pharmacophore- or int… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
57
1

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 56 publications
(58 citation statements)
references
References 38 publications
0
57
1
Order By: Relevance
“…As can be seen, 40% of the actives were both recovered in the top 5% of ranked NCI and HitFinder diversity set. Overall, a state-of-the-art virtual screening tool rarely extracts 100% of the actives in the top 10% and even more rarely in the top 5%; 50-60% in the top 5% is more commonly observed with the best programs [47]. In addition, considering that all the actives are low micromolar lead compounds and new actives is possible existing in the decoy set, the enrichment achieved by this docking protocol is reasonable and promising.…”
Section: Virtual Screening Against Diversity Setsmentioning
confidence: 92%
See 1 more Smart Citation
“…As can be seen, 40% of the actives were both recovered in the top 5% of ranked NCI and HitFinder diversity set. Overall, a state-of-the-art virtual screening tool rarely extracts 100% of the actives in the top 10% and even more rarely in the top 5%; 50-60% in the top 5% is more commonly observed with the best programs [47]. In addition, considering that all the actives are low micromolar lead compounds and new actives is possible existing in the decoy set, the enrichment achieved by this docking protocol is reasonable and promising.…”
Section: Virtual Screening Against Diversity Setsmentioning
confidence: 92%
“…It is common practice to see a library of drug-like molecules with known actives and use the enrichment factor obtained to evaluate the accuracy of the docking and scoring functions of the software [47]. Figure 6 shows the percentage of the number of known inhibitors retrieved when increasing the fraction of the ranked list.…”
Section: Virtual Screening Against Diversity Setsmentioning
confidence: 99%
“…Thus, the inclusion of the interaction sites oriented the docking toward better solutions and, as a result, afforded a 10% increase in accuracy over FITTED 1.0 and a significant decrease in required CPU time. 36 FITTED was then used in the screening of the Maybridge database against HCV polymerase and was successful in identifying two hits in the low micromolar range. 36 FITTED2.6.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, virtual screening methods are being considered as promising approaches to accelerate drug discovery. [57][58][59] In the present study, we successfully identified a potent inhibitor of HCV NS5B by using a structure-based virtual screening of the Maybridge Screening Collection and the in vitro cell-based reporter assay. If more diverse potential drug candidates can be identified, then greater is the possibility of developing new therapies for inhibiting HCV.…”
Section: Discussionmentioning
confidence: 99%